该职位已失效,看看其他机会吧

Quality Assurance associate

1.2万-1.8万·13薪
  • 上海静安区
  • 1-3年
  • 本科
  • 全职
  • 招1人

职位描述

QA

MAJOR AREAS OF RESPONSIBILITY:

- Perform on site oversight of manufacturing and quality control testing performed by XingImaging’s subcontracted manufacturing organizations. Track and report to management any deviations from procedures.

-Participate in the on-site conduction of investigations related to non-conformance events.

-Issue and review daily production batch records.

-Review and approve requalification/calibration reports and certificates

-Participate in the development and approval of necessary documentation for the manufacturing of radiopharmaceuticals at the CMO (master batch record, testing standard, validation plan, SOP, WID)

-Participate in the oversight of document control systems to assure all
essential documents (batch records, Excel spreadsheets, SOPs) are accurately controlled and distributed properly to XingImaging’s subcontracted
manufacturing organizations.

- Ensure proper and timely implementation of corrective/preventative actions by XingImaging’s subcontracted manufacturing organizations.

- Ensure XingImaging’s subcontracted manufacturing organizations follow the instructions included in provided protocols when conducting validation activities. Review CMO validation raw data (analytical and process) for accuracy and integrity.

- Contribute to the completion and filing of training documentation, certification and licenses for XingImaging’s subcontracted manufacturing organizations employees.

- Other tasks as assigned by supervisor.


QUALIFICATIONS AND REQUIREMENTS:
- Minimum of Bachelor’s degree in science related field
- 1-2 Years experience working in a GMP environment
- Good knowledge of radiopharmaceutical regulation
- good English skills, both oral and written.

查看全部

奖金绩效

年终奖

工作地点

上海市静安区乌鲁木齐中路12号

职位发布者

邹燕/人事主管

立即沟通
公司Logo米度(南京)生物技术有限公司
米度(南京)生物技术有限公司,简称米度生物(MITRO Biotec),专注于分子影像转化医学研究,主要从事分子影像药物研发外包、药物标记合成、新型核医学示踪剂及分子探针研究、肿瘤靶向治疗技术研究。米度生物利用先进核医学设备和活体分子影像技术,为新药研发提供从动物到人体的全流程技术服务。临床前研究方面,通过活体分子影像技术,动态、定量、精准获取小动物体内药代动力学(PK)和药效学(PD)数据,对国内外制药企业、高校院所、临床医疗机构等提供从药物筛选、分布代谢、疗效及安全性评价等的一系列的药物研发整体解决方案和全套技术服务,帮助客户降低药研成本、缩短研发周期、加快新药上市。临床研究方面,利用人体PET、SPECT等先进分子影像技术手段,开展临床0期(人体微剂量,HumanMicrodosing)研究及指导个体化医疗(Personalized Medicine)实践,加快药物研发,降低失败风险,服务百姓健康,为科研成果直接转化开辟出新途径。分子影像技术具有活体显像、自身对照、连续观察、动态定量等特点,缩短研发周期、加快新药上市。
公司主页